The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2023

Filed:

Dec. 20, 2021
Applicant:

Brien Holden Vision Institute Limited, Sydney, AU;

Inventors:

Arthur Back, Danville, CA (US);

Padmaja Rajagopal Sankaridurg, Maroubra, AU;

Cathleen Fedtke, Casula, AU;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 9/00 (2006.01); A61K 31/46 (2006.01); G02C 7/04 (2006.01); G02C 7/02 (2006.01); A61F 2/16 (2006.01); A61K 9/00 (2006.01); G02B 21/08 (2006.01);
U.S. Cl.
CPC ...
A61F 9/0017 (2013.01); A61F 2/1637 (2013.01); A61K 31/46 (2013.01); G02B 21/08 (2013.01); G02C 7/021 (2013.01); G02C 7/022 (2013.01); G02C 7/027 (2013.01); G02C 7/04 (2013.01); A61K 9/0051 (2013.01);
Abstract

An ophthalmic lens for treating myopia comprising: a base lens with a front surface, a back surface, and a first power profile selected to correct or substantially correct for a distance refractive error of the eye; one or more myopia control elements on at least one of the front and back surfaces of the lens; a first viewing region having a dimension selected based, at least in part, on a concentration of a pharmaceutical agent for use in conjunction with an ophthalmic lens, the first viewing region being configured to minimize, reduce and/or eliminate vision disturbances for distance vision; and a second viewing region comprising a power profile that is relatively more positive compared to the first viewing region; wherein at least one of the size of the second viewing region and the relatively more positive power of the second viewing region is selected based, at least in part, on the concentration of the pharmaceutical agent.


Find Patent Forward Citations

Loading…